These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15849907)

  • 21. [Determination of risk factors of smear-negative pulmonary tuberculosis].
    Toure NO; Diatta A; Dia Y; Niang A; Ndiaye EH; Thiam K; Kandji M; Toure YK; Sow D; Wone A; Diop BM; Hane AA
    Dakar Med; 2005; 50(3):98-103. PubMed ID: 17632989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ocular complications of HIV/AIDS in Cameroon: is there is any correlation with the level of CD4 lymphocytes count?].
    Ebana Mvogo C; Ellong A; Bella AL; Luma H; Achu Joko H
    Bull Soc Belge Ophtalmol; 2007; (305):7-12. PubMed ID: 18018421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis in HIV/AIDS patients: a Malaysian experience.
    Nissapatorn V; Kuppusamy I; Sim BL; Quek KF; Khairul Anuar A
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):946-53. PubMed ID: 16295550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
    J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on clinico-epidemiological profile of HIV patients in eastern India.
    Chakravarty J; Mehta H; Parekh A; Attili SV; Agrawal NR; Singh SP; Sundar S
    J Assoc Physicians India; 2006 Nov; 54():854-7. PubMed ID: 17249252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disseminated tuberculosis with cutaneous manifestations in AIDS patients. Presentation of 4 cases].
    Esquivel SP; Vigna L; Velázquez J; Cangelosi D; Figueiras O; Solari R; Corti M; Massini R
    Enferm Infecc Microbiol Clin; 1998 Jan; 16(1):31-4. PubMed ID: 9542307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing QuantiFERON-tuberculosis gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country.
    Stephan C; Wolf T; Goetsch U; Bellinger O; Nisius G; Oremek G; Rakus Z; Gottschalk R; Stark S; Brodt HR; Staszewski S
    AIDS; 2008 Nov; 22(18):2471-9. PubMed ID: 19005270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The current and future situations of TB/HIV (co-infection of tuberculosis and HIV) in Japan].
    Yamada N; Nagai H
    Kekkaku; 2009 Apr; 84(4):203-11. PubMed ID: 19425395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon.
    Josephine M; Issac E; George A; Ngole M; Albert SE
    Int J Dermatol; 2006 Mar; 45(3):280-4. PubMed ID: 16533229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tuberculosis among HIV infected patients].
    Olczak A; Grabczewska E; Kozielewicz D; Gorzelak B
    Przegl Epidemiol; 2008; 62(1):63-9. PubMed ID: 18536226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of tuberculosis and its impact on mortality among HIV infected patients in Chile].
    Villarroel L; Rabagliati R; Balcells ME; Karzulovic L; Pérez C
    Rev Med Chil; 2008 May; 136(5):578-86. PubMed ID: 18769804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preventive measures against tuberculosis in working facilities and companies].
    Suzuki K; Satou K
    Kekkaku; 2007 Mar; 82(3):201-16. PubMed ID: 17444125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Epidemiological and clinical features of HIV-2 infection in Dakar].
    Diouf A; Seydi M; Diop BM; Soumaré M; Ndour CT; Manga NM; Dia Badiane NM; Diop SA; Sow PS
    Med Mal Infect; 2007 Sep; 37(9):584-9. PubMed ID: 17306487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
    Wilhan ; Budiono E
    Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disseminated mycobacteriosis associated with Mycobacterium avium-intracellular (MAI) complex in HIV infected patients].
    Cuervo LM; Delgado FR; Guillot FB; García JC; Font ME; Cardoso EM
    Rev Cubana Med Trop; 2003; 55(2):126-8. PubMed ID: 15849972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serological diagnosis of syphilis in Cuban HIV/AIDS patients].
    Rodríguez I; Rodríguez ME; Fernández C; Blanco O; Llop A
    Rev Cubana Med Trop; 2004; 56(1):67-9. PubMed ID: 15849912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive factors of treatment interruption duration in a cohort of HIV-1 infected patients with CD4 count greater than 350 cells per mm3.
    Fillaux J; Delpierre C; Alvarez M; Jaafar A; Marchou B; Massip P; Cuzin L
    Med Mal Infect; 2006 Jun; 36(6):335-9. PubMed ID: 16631330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.